COVID-19 Impact on Global Ocular Drug Delivery, Market Insights and Forecast to 2026
Ocular Drug Delivery market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ocular Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Ocular Drug Delivery market is segmented into
The Ocular Drug Delivery market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ocular Drug Delivery market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ocular Drug Delivery Market Share Analysis
Ocular Drug Delivery market competitive landscape provides details and data information by players.
The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ocular Drug Delivery business, the date to enter into the Ocular Drug Delivery market, Ocular Drug Delivery product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Ocular Drug Delivery market is segmented into
- By Technology
- By Form
- Hospitals
- Ambulatory Surgical Centers
- Ophthalmic Clinics
- Homecare Settings
The Ocular Drug Delivery market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ocular Drug Delivery market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ocular Drug Delivery Market Share Analysis
Ocular Drug Delivery market competitive landscape provides details and data information by players.
The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ocular Drug Delivery business, the date to enter into the Ocular Drug Delivery market, Ocular Drug Delivery product introduction, recent developments, etc.
The major vendors covered:
- OCULAR THERAPEUTIX, INC
- Alimera Sciences
- Allergan, Plc
- EyeGate Pharma
- Valeant Pharmaceuticals International, Inc
- Envisia Therapeutics
- Clearside Biomedical
- Graybug Vision Inc
- Taiwan Liposome Company
- Santen Pharmaceutical
1 STUDY COVERAGE
1.1 Ocular Drug Delivery Product Introduction
1.2 Market Segments
1.3 Key Ocular Drug Delivery Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Ocular Drug Delivery Market Size Growth Rate by Type
1.4.2 Type I
1.4.3 Type II
1.5 Market by Application
1.5.1 Global Ocular Drug Delivery Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Ophthalmic Clinics
1.5.5 Homecare Settings
1.6 Coronavirus Disease 2019 (Covid-19): Ocular Drug Delivery Industry Impact
1.6.1 How the Covid-19 is Affecting the Ocular Drug Delivery Industry
1.6.1.1 Ocular Drug Delivery Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Ocular Drug Delivery Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Ocular Drug Delivery Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Ocular Drug Delivery Market Size Estimates and Forecasts
2.1.1 Global Ocular Drug Delivery Revenue 2015-2026
2.1.2 Global Ocular Drug Delivery Sales 2015-2026
2.2 Ocular Drug Delivery Market Size by Region: 2020 Versus 2026
2.2.1 Global Ocular Drug Delivery Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Ocular Drug Delivery Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL OCULAR DRUG DELIVERY COMPETITOR LANDSCAPE BY PLAYERS
3.1 Ocular Drug Delivery Sales by Manufacturers
3.1.1 Ocular Drug Delivery Sales by Manufacturers (2015-2020)
3.1.2 Ocular Drug Delivery Sales Market Share by Manufacturers (2015-2020)
3.2 Ocular Drug Delivery Revenue by Manufacturers
3.2.1 Ocular Drug Delivery Revenue by Manufacturers (2015-2020)
3.2.2 Ocular Drug Delivery Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ocular Drug Delivery Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Ocular Drug Delivery Revenue in 2019
3.2.5 Global Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Ocular Drug Delivery Price by Manufacturers
3.4 Ocular Drug Delivery Manufacturing Base Distribution, Product Types
3.4.1 Ocular Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ocular Drug Delivery Product Type
3.4.3 Date of International Manufacturers Enter into Ocular Drug Delivery Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Ocular Drug Delivery Market Size by Type (2015-2020)
4.1.1 Global Ocular Drug Delivery Sales by Type (2015-2020)
4.1.2 Global Ocular Drug Delivery Revenue by Type (2015-2020)
4.1.3 Ocular Drug Delivery Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Ocular Drug Delivery Market Size Forecast by Type (2021-2026)
4.2.1 Global Ocular Drug Delivery Sales Forecast by Type (2021-2026)
4.2.2 Global Ocular Drug Delivery Revenue Forecast by Type (2021-2026)
4.2.3 Ocular Drug Delivery Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Ocular Drug Delivery Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Ocular Drug Delivery Market Size by Application (2015-2020)
5.1.1 Global Ocular Drug Delivery Sales by Application (2015-2020)
5.1.2 Global Ocular Drug Delivery Revenue by Application (2015-2020)
5.1.3 Ocular Drug Delivery Price by Application (2015-2020)
5.2 Ocular Drug Delivery Market Size Forecast by Application (2021-2026)
5.2.1 Global Ocular Drug Delivery Sales Forecast by Application (2021-2026)
5.2.2 Global Ocular Drug Delivery Revenue Forecast by Application (2021-2026)
5.2.3 Global Ocular Drug Delivery Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Ocular Drug Delivery by Country
6.1.1 North America Ocular Drug Delivery Sales by Country
6.1.2 North America Ocular Drug Delivery Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Ocular Drug Delivery Market Facts & Figures by Type
6.3 North America Ocular Drug Delivery Market Facts & Figures by Application
7 EUROPE
7.1 Europe Ocular Drug Delivery by Country
7.1.1 Europe Ocular Drug Delivery Sales by Country
7.1.2 Europe Ocular Drug Delivery Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ocular Drug Delivery Market Facts & Figures by Type
7.3 Europe Ocular Drug Delivery Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Ocular Drug Delivery by Region
8.1.1 Asia Pacific Ocular Drug Delivery Sales by Region
8.1.2 Asia Pacific Ocular Drug Delivery Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Ocular Drug Delivery Market Facts & Figures by Type
8.3 Asia Pacific Ocular Drug Delivery Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Ocular Drug Delivery by Country
9.1.1 Latin America Ocular Drug Delivery Sales by Country
9.1.2 Latin America Ocular Drug Delivery Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Ocular Drug Delivery Market Facts & Figures by Type
9.3 Central & South America Ocular Drug Delivery Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Ocular Drug Delivery by Country
10.1.1 Middle East and Africa Ocular Drug Delivery Sales by Country
10.1.2 Middle East and Africa Ocular Drug Delivery Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Ocular Drug Delivery Market Facts & Figures by Type
10.3 Middle East and Africa Ocular Drug Delivery Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 OCULAR THERAPEUTIX, INC
11.1.1 OCULAR THERAPEUTIX, INC Corporation Information
11.1.2 OCULAR THERAPEUTIX, INC Description, Business Overview and Total Revenue
11.1.3 OCULAR THERAPEUTIX, INC Sales, Revenue and Gross Margin (2015-2020)
11.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Products Offered
11.1.5 OCULAR THERAPEUTIX, INC Recent Development
11.2 Alimera Sciences
11.2.1 Alimera Sciences Corporation Information
11.2.2 Alimera Sciences Description, Business Overview and Total Revenue
11.2.3 Alimera Sciences Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Alimera Sciences Ocular Drug Delivery Products Offered
11.2.5 Alimera Sciences Recent Development
11.3 Allergan, Plc
11.3.1 Allergan, Plc Corporation Information
11.3.2 Allergan, Plc Description, Business Overview and Total Revenue
11.3.3 Allergan, Plc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Allergan, Plc Ocular Drug Delivery Products Offered
11.3.5 Allergan, Plc Recent Development
11.4 EyeGate Pharma
11.4.1 EyeGate Pharma Corporation Information
11.4.2 EyeGate Pharma Description, Business Overview and Total Revenue
11.4.3 EyeGate Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 EyeGate Pharma Ocular Drug Delivery Products Offered
11.4.5 EyeGate Pharma Recent Development
11.5 Valeant Pharmaceuticals International, Inc
11.5.1 Valeant Pharmaceuticals International, Inc Corporation Information
11.5.2 Valeant Pharmaceuticals International, Inc Description, Business Overview and Total Revenue
11.5.3 Valeant Pharmaceuticals International, Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Products Offered
11.5.5 Valeant Pharmaceuticals International, Inc Recent Development
11.6 Envisia Therapeutics
11.6.1 Envisia Therapeutics Corporation Information
11.6.2 Envisia Therapeutics Description, Business Overview and Total Revenue
11.6.3 Envisia Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Envisia Therapeutics Ocular Drug Delivery Products Offered
11.6.5 Envisia Therapeutics Recent Development
11.7 Clearside Biomedical
11.7.1 Clearside Biomedical Corporation Information
11.7.2 Clearside Biomedical Description, Business Overview and Total Revenue
11.7.3 Clearside Biomedical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Clearside Biomedical Ocular Drug Delivery Products Offered
11.7.5 Clearside Biomedical Recent Development
11.8 Graybug Vision Inc
11.8.1 Graybug Vision Inc Corporation Information
11.8.2 Graybug Vision Inc Description, Business Overview and Total Revenue
11.8.3 Graybug Vision Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Graybug Vision Inc Ocular Drug Delivery Products Offered
11.8.5 Graybug Vision Inc Recent Development
11.9 Taiwan Liposome Company
11.9.1 Taiwan Liposome Company Corporation Information
11.9.2 Taiwan Liposome Company Description, Business Overview and Total Revenue
11.9.3 Taiwan Liposome Company Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Taiwan Liposome Company Ocular Drug Delivery Products Offered
11.9.5 Taiwan Liposome Company Recent Development
11.10 Santen Pharmaceutical
11.10.1 Santen Pharmaceutical Corporation Information
11.10.2 Santen Pharmaceutical Description, Business Overview and Total Revenue
11.10.3 Santen Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Santen Pharmaceutical Ocular Drug Delivery Products Offered
11.10.5 Santen Pharmaceutical Recent Development
11.1 OCULAR THERAPEUTIX, INC
11.1.1 OCULAR THERAPEUTIX, INC Corporation Information
11.1.2 OCULAR THERAPEUTIX, INC Description, Business Overview and Total Revenue
11.1.3 OCULAR THERAPEUTIX, INC Sales, Revenue and Gross Margin (2015-2020)
11.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Products Offered
11.1.5 OCULAR THERAPEUTIX, INC Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Ocular Drug Delivery Market Estimates and Projections by Region
12.1.1 Global Ocular Drug Delivery Sales Forecast by Regions 2021-2026
12.1.2 Global Ocular Drug Delivery Revenue Forecast by Regions 2021-2026
12.2 North America Ocular Drug Delivery Market Size Forecast (2021-2026)
12.2.1 North America: Ocular Drug Delivery Sales Forecast (2021-2026)
12.2.2 North America: Ocular Drug Delivery Revenue Forecast (2021-2026)
12.2.3 North America: Ocular Drug Delivery Market Size Forecast by Country (2021-2026)
12.3 Europe Ocular Drug Delivery Market Size Forecast (2021-2026)
12.3.1 Europe: Ocular Drug Delivery Sales Forecast (2021-2026)
12.3.2 Europe: Ocular Drug Delivery Revenue Forecast (2021-2026)
12.3.3 Europe: Ocular Drug Delivery Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Ocular Drug Delivery Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Ocular Drug Delivery Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Ocular Drug Delivery Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Ocular Drug Delivery Market Size Forecast by Region (2021-2026)
12.5 Latin America Ocular Drug Delivery Market Size Forecast (2021-2026)
12.5.1 Latin America: Ocular Drug Delivery Sales Forecast (2021-2026)
12.5.2 Latin America: Ocular Drug Delivery Revenue Forecast (2021-2026)
12.5.3 Latin America: Ocular Drug Delivery Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Ocular Drug Delivery Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Ocular Drug Delivery Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Ocular Drug Delivery Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Ocular Drug Delivery Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Ocular Drug Delivery Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Ocular Drug Delivery Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Ocular Drug Delivery Product Introduction
1.2 Market Segments
1.3 Key Ocular Drug Delivery Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Ocular Drug Delivery Market Size Growth Rate by Type
1.4.2 Type I
1.4.3 Type II
1.5 Market by Application
1.5.1 Global Ocular Drug Delivery Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Ophthalmic Clinics
1.5.5 Homecare Settings
1.6 Coronavirus Disease 2019 (Covid-19): Ocular Drug Delivery Industry Impact
1.6.1 How the Covid-19 is Affecting the Ocular Drug Delivery Industry
1.6.1.1 Ocular Drug Delivery Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Ocular Drug Delivery Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Ocular Drug Delivery Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Ocular Drug Delivery Market Size Estimates and Forecasts
2.1.1 Global Ocular Drug Delivery Revenue 2015-2026
2.1.2 Global Ocular Drug Delivery Sales 2015-2026
2.2 Ocular Drug Delivery Market Size by Region: 2020 Versus 2026
2.2.1 Global Ocular Drug Delivery Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Ocular Drug Delivery Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL OCULAR DRUG DELIVERY COMPETITOR LANDSCAPE BY PLAYERS
3.1 Ocular Drug Delivery Sales by Manufacturers
3.1.1 Ocular Drug Delivery Sales by Manufacturers (2015-2020)
3.1.2 Ocular Drug Delivery Sales Market Share by Manufacturers (2015-2020)
3.2 Ocular Drug Delivery Revenue by Manufacturers
3.2.1 Ocular Drug Delivery Revenue by Manufacturers (2015-2020)
3.2.2 Ocular Drug Delivery Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ocular Drug Delivery Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Ocular Drug Delivery Revenue in 2019
3.2.5 Global Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Ocular Drug Delivery Price by Manufacturers
3.4 Ocular Drug Delivery Manufacturing Base Distribution, Product Types
3.4.1 Ocular Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ocular Drug Delivery Product Type
3.4.3 Date of International Manufacturers Enter into Ocular Drug Delivery Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Ocular Drug Delivery Market Size by Type (2015-2020)
4.1.1 Global Ocular Drug Delivery Sales by Type (2015-2020)
4.1.2 Global Ocular Drug Delivery Revenue by Type (2015-2020)
4.1.3 Ocular Drug Delivery Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Ocular Drug Delivery Market Size Forecast by Type (2021-2026)
4.2.1 Global Ocular Drug Delivery Sales Forecast by Type (2021-2026)
4.2.2 Global Ocular Drug Delivery Revenue Forecast by Type (2021-2026)
4.2.3 Ocular Drug Delivery Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Ocular Drug Delivery Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Ocular Drug Delivery Market Size by Application (2015-2020)
5.1.1 Global Ocular Drug Delivery Sales by Application (2015-2020)
5.1.2 Global Ocular Drug Delivery Revenue by Application (2015-2020)
5.1.3 Ocular Drug Delivery Price by Application (2015-2020)
5.2 Ocular Drug Delivery Market Size Forecast by Application (2021-2026)
5.2.1 Global Ocular Drug Delivery Sales Forecast by Application (2021-2026)
5.2.2 Global Ocular Drug Delivery Revenue Forecast by Application (2021-2026)
5.2.3 Global Ocular Drug Delivery Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Ocular Drug Delivery by Country
6.1.1 North America Ocular Drug Delivery Sales by Country
6.1.2 North America Ocular Drug Delivery Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Ocular Drug Delivery Market Facts & Figures by Type
6.3 North America Ocular Drug Delivery Market Facts & Figures by Application
7 EUROPE
7.1 Europe Ocular Drug Delivery by Country
7.1.1 Europe Ocular Drug Delivery Sales by Country
7.1.2 Europe Ocular Drug Delivery Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ocular Drug Delivery Market Facts & Figures by Type
7.3 Europe Ocular Drug Delivery Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Ocular Drug Delivery by Region
8.1.1 Asia Pacific Ocular Drug Delivery Sales by Region
8.1.2 Asia Pacific Ocular Drug Delivery Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Ocular Drug Delivery Market Facts & Figures by Type
8.3 Asia Pacific Ocular Drug Delivery Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Ocular Drug Delivery by Country
9.1.1 Latin America Ocular Drug Delivery Sales by Country
9.1.2 Latin America Ocular Drug Delivery Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Ocular Drug Delivery Market Facts & Figures by Type
9.3 Central & South America Ocular Drug Delivery Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Ocular Drug Delivery by Country
10.1.1 Middle East and Africa Ocular Drug Delivery Sales by Country
10.1.2 Middle East and Africa Ocular Drug Delivery Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Ocular Drug Delivery Market Facts & Figures by Type
10.3 Middle East and Africa Ocular Drug Delivery Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 OCULAR THERAPEUTIX, INC
11.1.1 OCULAR THERAPEUTIX, INC Corporation Information
11.1.2 OCULAR THERAPEUTIX, INC Description, Business Overview and Total Revenue
11.1.3 OCULAR THERAPEUTIX, INC Sales, Revenue and Gross Margin (2015-2020)
11.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Products Offered
11.1.5 OCULAR THERAPEUTIX, INC Recent Development
11.2 Alimera Sciences
11.2.1 Alimera Sciences Corporation Information
11.2.2 Alimera Sciences Description, Business Overview and Total Revenue
11.2.3 Alimera Sciences Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Alimera Sciences Ocular Drug Delivery Products Offered
11.2.5 Alimera Sciences Recent Development
11.3 Allergan, Plc
11.3.1 Allergan, Plc Corporation Information
11.3.2 Allergan, Plc Description, Business Overview and Total Revenue
11.3.3 Allergan, Plc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Allergan, Plc Ocular Drug Delivery Products Offered
11.3.5 Allergan, Plc Recent Development
11.4 EyeGate Pharma
11.4.1 EyeGate Pharma Corporation Information
11.4.2 EyeGate Pharma Description, Business Overview and Total Revenue
11.4.3 EyeGate Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 EyeGate Pharma Ocular Drug Delivery Products Offered
11.4.5 EyeGate Pharma Recent Development
11.5 Valeant Pharmaceuticals International, Inc
11.5.1 Valeant Pharmaceuticals International, Inc Corporation Information
11.5.2 Valeant Pharmaceuticals International, Inc Description, Business Overview and Total Revenue
11.5.3 Valeant Pharmaceuticals International, Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Products Offered
11.5.5 Valeant Pharmaceuticals International, Inc Recent Development
11.6 Envisia Therapeutics
11.6.1 Envisia Therapeutics Corporation Information
11.6.2 Envisia Therapeutics Description, Business Overview and Total Revenue
11.6.3 Envisia Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Envisia Therapeutics Ocular Drug Delivery Products Offered
11.6.5 Envisia Therapeutics Recent Development
11.7 Clearside Biomedical
11.7.1 Clearside Biomedical Corporation Information
11.7.2 Clearside Biomedical Description, Business Overview and Total Revenue
11.7.3 Clearside Biomedical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Clearside Biomedical Ocular Drug Delivery Products Offered
11.7.5 Clearside Biomedical Recent Development
11.8 Graybug Vision Inc
11.8.1 Graybug Vision Inc Corporation Information
11.8.2 Graybug Vision Inc Description, Business Overview and Total Revenue
11.8.3 Graybug Vision Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Graybug Vision Inc Ocular Drug Delivery Products Offered
11.8.5 Graybug Vision Inc Recent Development
11.9 Taiwan Liposome Company
11.9.1 Taiwan Liposome Company Corporation Information
11.9.2 Taiwan Liposome Company Description, Business Overview and Total Revenue
11.9.3 Taiwan Liposome Company Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Taiwan Liposome Company Ocular Drug Delivery Products Offered
11.9.5 Taiwan Liposome Company Recent Development
11.10 Santen Pharmaceutical
11.10.1 Santen Pharmaceutical Corporation Information
11.10.2 Santen Pharmaceutical Description, Business Overview and Total Revenue
11.10.3 Santen Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Santen Pharmaceutical Ocular Drug Delivery Products Offered
11.10.5 Santen Pharmaceutical Recent Development
11.1 OCULAR THERAPEUTIX, INC
11.1.1 OCULAR THERAPEUTIX, INC Corporation Information
11.1.2 OCULAR THERAPEUTIX, INC Description, Business Overview and Total Revenue
11.1.3 OCULAR THERAPEUTIX, INC Sales, Revenue and Gross Margin (2015-2020)
11.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Products Offered
11.1.5 OCULAR THERAPEUTIX, INC Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Ocular Drug Delivery Market Estimates and Projections by Region
12.1.1 Global Ocular Drug Delivery Sales Forecast by Regions 2021-2026
12.1.2 Global Ocular Drug Delivery Revenue Forecast by Regions 2021-2026
12.2 North America Ocular Drug Delivery Market Size Forecast (2021-2026)
12.2.1 North America: Ocular Drug Delivery Sales Forecast (2021-2026)
12.2.2 North America: Ocular Drug Delivery Revenue Forecast (2021-2026)
12.2.3 North America: Ocular Drug Delivery Market Size Forecast by Country (2021-2026)
12.3 Europe Ocular Drug Delivery Market Size Forecast (2021-2026)
12.3.1 Europe: Ocular Drug Delivery Sales Forecast (2021-2026)
12.3.2 Europe: Ocular Drug Delivery Revenue Forecast (2021-2026)
12.3.3 Europe: Ocular Drug Delivery Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Ocular Drug Delivery Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Ocular Drug Delivery Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Ocular Drug Delivery Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Ocular Drug Delivery Market Size Forecast by Region (2021-2026)
12.5 Latin America Ocular Drug Delivery Market Size Forecast (2021-2026)
12.5.1 Latin America: Ocular Drug Delivery Sales Forecast (2021-2026)
12.5.2 Latin America: Ocular Drug Delivery Revenue Forecast (2021-2026)
12.5.3 Latin America: Ocular Drug Delivery Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Ocular Drug Delivery Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Ocular Drug Delivery Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Ocular Drug Delivery Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Ocular Drug Delivery Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Ocular Drug Delivery Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Ocular Drug Delivery Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Ocular Drug Delivery Market Segments
Table 2. Ranking of Global Top Ocular Drug Delivery Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Ocular Drug Delivery Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Type I
Table 5. Major Manufacturers of Type II
Table 6. COVID-19 Impact Global Market: (Four Ocular Drug Delivery Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Ocular Drug Delivery Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Ocular Drug Delivery Players to Combat Covid-19 Impact
Table 11. Global Ocular Drug Delivery Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 12. Global Ocular Drug Delivery Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 13. Global Ocular Drug Delivery Sales by Regions 2015-2020 (K Doses)
Table 14. Global Ocular Drug Delivery Sales Market Share by Regions (2015-2020)
Table 15. Global Ocular Drug Delivery Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Ocular Drug Delivery Sales by Manufacturers (2015-2020) (K Doses)
Table 17. Global Ocular Drug Delivery Sales Share by Manufacturers (2015-2020)
Table 18. Global Ocular Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Ocular Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ocular Drug Delivery as of 2019)
Table 20. Ocular Drug Delivery Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Ocular Drug Delivery Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Ocular Drug Delivery Price (2015-2020) (USD/Dose)
Table 23. Ocular Drug Delivery Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Ocular Drug Delivery Product Type
Table 25. Date of International Manufacturers Enter into Ocular Drug Delivery Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Ocular Drug Delivery Sales by Type (2015-2020) (K Doses)
Table 28. Global Ocular Drug Delivery Sales Share by Type (2015-2020)
Table 29. Global Ocular Drug Delivery Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Ocular Drug Delivery Revenue Share by Type (2015-2020)
Table 31. Ocular Drug Delivery Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 32. Global Ocular Drug Delivery Sales by Application (2015-2020) (K Doses)
Table 33. Global Ocular Drug Delivery Sales Share by Application (2015-2020)
Table 34. North America Ocular Drug Delivery Sales by Country (2015-2020) (K Doses)
Table 35. North America Ocular Drug Delivery Sales Market Share by Country (2015-2020)
Table 36. North America Ocular Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Ocular Drug Delivery Revenue Market Share by Country (2015-2020)
Table 38. North America Ocular Drug Delivery Sales by Type (2015-2020) (K Doses)
Table 39. North America Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Table 40. North America Ocular Drug Delivery Sales by Application (2015-2020) (K Doses)
Table 41. North America Ocular Drug Delivery Sales Market Share by Application (2015-2020)
Table 42. Europe Ocular Drug Delivery Sales by Country (2015-2020) (K Doses)
Table 43. Europe Ocular Drug Delivery Sales Market Share by Country (2015-2020)
Table 44. Europe Ocular Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Ocular Drug Delivery Revenue Market Share by Country (2015-2020)
Table 46. Europe Ocular Drug Delivery Sales by Type (2015-2020) (K Doses)
Table 47. Europe Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Table 48. Europe Ocular Drug Delivery Sales by Application (2015-2020) (K Doses)
Table 49. Europe Ocular Drug Delivery Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Ocular Drug Delivery Sales by Region (2015-2020) (K Doses)
Table 51. Asia Pacific Ocular Drug Delivery Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Ocular Drug Delivery Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Ocular Drug Delivery Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Ocular Drug Delivery Sales by Type (2015-2020) (K Doses)
Table 55. Asia Pacific Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Ocular Drug Delivery Sales by Application (2015-2020) (K Doses)
Table 57. Asia Pacific Ocular Drug Delivery Sales Market Share by Application (2015-2020)
Table 58. Latin America Ocular Drug Delivery Sales by Country (2015-2020) (K Doses)
Table 59. Latin America Ocular Drug Delivery Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Ocular Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Ocular Drug Delivery Revenue Market Share by Country (2015-2020)
Table 62. Latin America Ocular Drug Delivery Sales by Type (2015-2020) (K Doses)
Table 63. Latin America Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Table 64. Latin America Ocular Drug Delivery Sales by Application (2015-2020) (K Doses)
Table 65. Latin America Ocular Drug Delivery Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Ocular Drug Delivery Sales by Country (2015-2020) (K Doses)
Table 67. Middle East and Africa Ocular Drug Delivery Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Ocular Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Ocular Drug Delivery Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Ocular Drug Delivery Sales by Type (2015-2020) (K Doses)
Table 71. Middle East and Africa Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Ocular Drug Delivery Sales by Application (2015-2020) (K Doses)
Table 73. Middle East and Africa Ocular Drug Delivery Sales Market Share by Application (2015-2020)
Table 74. OCULAR THERAPEUTIX, INC Corporation Information
Table 75. OCULAR THERAPEUTIX, INC Description and Major Businesses
Table 76. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. OCULAR THERAPEUTIX, INC Product
Table 78. OCULAR THERAPEUTIX, INC Recent Development
Table 79. Alimera Sciences Corporation Information
Table 80. Alimera Sciences Description and Major Businesses
Table 81. Alimera Sciences Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. Alimera Sciences Product
Table 83. Alimera Sciences Recent Development
Table 84. Allergan, Plc Corporation Information
Table 85. Allergan, Plc Description and Major Businesses
Table 86. Allergan, Plc Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. Allergan, Plc Product
Table 88. Allergan, Plc Recent Development
Table 89. EyeGate Pharma Corporation Information
Table 90. EyeGate Pharma Description and Major Businesses
Table 91. EyeGate Pharma Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 92. EyeGate Pharma Product
Table 93. EyeGate Pharma Recent Development
Table 94. Valeant Pharmaceuticals International, Inc Corporation Information
Table 95. Valeant Pharmaceuticals International, Inc Description and Major Businesses
Table 96. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. Valeant Pharmaceuticals International, Inc Product
Table 98. Valeant Pharmaceuticals International, Inc Recent Development
Table 99. Envisia Therapeutics Corporation Information
Table 100. Envisia Therapeutics Description and Major Businesses
Table 101. Envisia Therapeutics Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. Envisia Therapeutics Product
Table 103. Envisia Therapeutics Recent Development
Table 104. Clearside Biomedical Corporation Information
Table 105. Clearside Biomedical Description and Major Businesses
Table 106. Clearside Biomedical Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 107. Clearside Biomedical Product
Table 108. Clearside Biomedical Recent Development
Table 109. Graybug Vision Inc Corporation Information
Table 110. Graybug Vision Inc Description and Major Businesses
Table 111. Graybug Vision Inc Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Graybug Vision Inc Product
Table 113. Graybug Vision Inc Recent Development
Table 114. Taiwan Liposome Company Corporation Information
Table 115. Taiwan Liposome Company Description and Major Businesses
Table 116. Taiwan Liposome Company Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Taiwan Liposome Company Product
Table 118. Taiwan Liposome Company Recent Development
Table 119. Santen Pharmaceutical Corporation Information
Table 120. Santen Pharmaceutical Description and Major Businesses
Table 121. Santen Pharmaceutical Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. Santen Pharmaceutical Product
Table 123. Santen Pharmaceutical Recent Development
Table 124. Global Ocular Drug Delivery Sales Forecast by Regions (2021-2026) (K Doses)
Table 125. Global Ocular Drug Delivery Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Ocular Drug Delivery Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Ocular Drug Delivery Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Ocular Drug Delivery Sales Forecast by Country (2021-2026) (K Doses)
Table 129. North America: Ocular Drug Delivery Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Ocular Drug Delivery Sales Forecast by Country (2021-2026) (K Doses)
Table 131. Europe: Ocular Drug Delivery Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Ocular Drug Delivery Sales Forecast by Region (2021-2026) (K Doses)
Table 133. Asia Pacific: Ocular Drug Delivery Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Ocular Drug Delivery Sales Forecast by Country (2021-2026) (K Doses)
Table 135. Latin America: Ocular Drug Delivery Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Ocular Drug Delivery Sales Forecast by Country (2021-2026) (K Doses)
Table 137. Middle East and Africa: Ocular Drug Delivery Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Ocular Drug Delivery Players
Table 142. Ocular Drug Delivery Customers List
Table 143. Ocular Drug Delivery Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
Table 1. Ocular Drug Delivery Market Segments
Table 2. Ranking of Global Top Ocular Drug Delivery Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Ocular Drug Delivery Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Type I
Table 5. Major Manufacturers of Type II
Table 6. COVID-19 Impact Global Market: (Four Ocular Drug Delivery Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Ocular Drug Delivery Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Ocular Drug Delivery Players to Combat Covid-19 Impact
Table 11. Global Ocular Drug Delivery Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 12. Global Ocular Drug Delivery Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 13. Global Ocular Drug Delivery Sales by Regions 2015-2020 (K Doses)
Table 14. Global Ocular Drug Delivery Sales Market Share by Regions (2015-2020)
Table 15. Global Ocular Drug Delivery Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Ocular Drug Delivery Sales by Manufacturers (2015-2020) (K Doses)
Table 17. Global Ocular Drug Delivery Sales Share by Manufacturers (2015-2020)
Table 18. Global Ocular Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Ocular Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ocular Drug Delivery as of 2019)
Table 20. Ocular Drug Delivery Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Ocular Drug Delivery Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Ocular Drug Delivery Price (2015-2020) (USD/Dose)
Table 23. Ocular Drug Delivery Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Ocular Drug Delivery Product Type
Table 25. Date of International Manufacturers Enter into Ocular Drug Delivery Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Ocular Drug Delivery Sales by Type (2015-2020) (K Doses)
Table 28. Global Ocular Drug Delivery Sales Share by Type (2015-2020)
Table 29. Global Ocular Drug Delivery Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Ocular Drug Delivery Revenue Share by Type (2015-2020)
Table 31. Ocular Drug Delivery Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 32. Global Ocular Drug Delivery Sales by Application (2015-2020) (K Doses)
Table 33. Global Ocular Drug Delivery Sales Share by Application (2015-2020)
Table 34. North America Ocular Drug Delivery Sales by Country (2015-2020) (K Doses)
Table 35. North America Ocular Drug Delivery Sales Market Share by Country (2015-2020)
Table 36. North America Ocular Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Ocular Drug Delivery Revenue Market Share by Country (2015-2020)
Table 38. North America Ocular Drug Delivery Sales by Type (2015-2020) (K Doses)
Table 39. North America Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Table 40. North America Ocular Drug Delivery Sales by Application (2015-2020) (K Doses)
Table 41. North America Ocular Drug Delivery Sales Market Share by Application (2015-2020)
Table 42. Europe Ocular Drug Delivery Sales by Country (2015-2020) (K Doses)
Table 43. Europe Ocular Drug Delivery Sales Market Share by Country (2015-2020)
Table 44. Europe Ocular Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Ocular Drug Delivery Revenue Market Share by Country (2015-2020)
Table 46. Europe Ocular Drug Delivery Sales by Type (2015-2020) (K Doses)
Table 47. Europe Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Table 48. Europe Ocular Drug Delivery Sales by Application (2015-2020) (K Doses)
Table 49. Europe Ocular Drug Delivery Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Ocular Drug Delivery Sales by Region (2015-2020) (K Doses)
Table 51. Asia Pacific Ocular Drug Delivery Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Ocular Drug Delivery Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Ocular Drug Delivery Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Ocular Drug Delivery Sales by Type (2015-2020) (K Doses)
Table 55. Asia Pacific Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Ocular Drug Delivery Sales by Application (2015-2020) (K Doses)
Table 57. Asia Pacific Ocular Drug Delivery Sales Market Share by Application (2015-2020)
Table 58. Latin America Ocular Drug Delivery Sales by Country (2015-2020) (K Doses)
Table 59. Latin America Ocular Drug Delivery Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Ocular Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Ocular Drug Delivery Revenue Market Share by Country (2015-2020)
Table 62. Latin America Ocular Drug Delivery Sales by Type (2015-2020) (K Doses)
Table 63. Latin America Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Table 64. Latin America Ocular Drug Delivery Sales by Application (2015-2020) (K Doses)
Table 65. Latin America Ocular Drug Delivery Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Ocular Drug Delivery Sales by Country (2015-2020) (K Doses)
Table 67. Middle East and Africa Ocular Drug Delivery Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Ocular Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Ocular Drug Delivery Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Ocular Drug Delivery Sales by Type (2015-2020) (K Doses)
Table 71. Middle East and Africa Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Ocular Drug Delivery Sales by Application (2015-2020) (K Doses)
Table 73. Middle East and Africa Ocular Drug Delivery Sales Market Share by Application (2015-2020)
Table 74. OCULAR THERAPEUTIX, INC Corporation Information
Table 75. OCULAR THERAPEUTIX, INC Description and Major Businesses
Table 76. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. OCULAR THERAPEUTIX, INC Product
Table 78. OCULAR THERAPEUTIX, INC Recent Development
Table 79. Alimera Sciences Corporation Information
Table 80. Alimera Sciences Description and Major Businesses
Table 81. Alimera Sciences Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. Alimera Sciences Product
Table 83. Alimera Sciences Recent Development
Table 84. Allergan, Plc Corporation Information
Table 85. Allergan, Plc Description and Major Businesses
Table 86. Allergan, Plc Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. Allergan, Plc Product
Table 88. Allergan, Plc Recent Development
Table 89. EyeGate Pharma Corporation Information
Table 90. EyeGate Pharma Description and Major Businesses
Table 91. EyeGate Pharma Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 92. EyeGate Pharma Product
Table 93. EyeGate Pharma Recent Development
Table 94. Valeant Pharmaceuticals International, Inc Corporation Information
Table 95. Valeant Pharmaceuticals International, Inc Description and Major Businesses
Table 96. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. Valeant Pharmaceuticals International, Inc Product
Table 98. Valeant Pharmaceuticals International, Inc Recent Development
Table 99. Envisia Therapeutics Corporation Information
Table 100. Envisia Therapeutics Description and Major Businesses
Table 101. Envisia Therapeutics Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. Envisia Therapeutics Product
Table 103. Envisia Therapeutics Recent Development
Table 104. Clearside Biomedical Corporation Information
Table 105. Clearside Biomedical Description and Major Businesses
Table 106. Clearside Biomedical Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 107. Clearside Biomedical Product
Table 108. Clearside Biomedical Recent Development
Table 109. Graybug Vision Inc Corporation Information
Table 110. Graybug Vision Inc Description and Major Businesses
Table 111. Graybug Vision Inc Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Graybug Vision Inc Product
Table 113. Graybug Vision Inc Recent Development
Table 114. Taiwan Liposome Company Corporation Information
Table 115. Taiwan Liposome Company Description and Major Businesses
Table 116. Taiwan Liposome Company Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Taiwan Liposome Company Product
Table 118. Taiwan Liposome Company Recent Development
Table 119. Santen Pharmaceutical Corporation Information
Table 120. Santen Pharmaceutical Description and Major Businesses
Table 121. Santen Pharmaceutical Ocular Drug Delivery Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. Santen Pharmaceutical Product
Table 123. Santen Pharmaceutical Recent Development
Table 124. Global Ocular Drug Delivery Sales Forecast by Regions (2021-2026) (K Doses)
Table 125. Global Ocular Drug Delivery Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Ocular Drug Delivery Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Ocular Drug Delivery Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Ocular Drug Delivery Sales Forecast by Country (2021-2026) (K Doses)
Table 129. North America: Ocular Drug Delivery Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Ocular Drug Delivery Sales Forecast by Country (2021-2026) (K Doses)
Table 131. Europe: Ocular Drug Delivery Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Ocular Drug Delivery Sales Forecast by Region (2021-2026) (K Doses)
Table 133. Asia Pacific: Ocular Drug Delivery Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Ocular Drug Delivery Sales Forecast by Country (2021-2026) (K Doses)
Table 135. Latin America: Ocular Drug Delivery Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Ocular Drug Delivery Sales Forecast by Country (2021-2026) (K Doses)
Table 137. Middle East and Africa: Ocular Drug Delivery Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Ocular Drug Delivery Players
Table 142. Ocular Drug Delivery Customers List
Table 143. Ocular Drug Delivery Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Ocular Drug Delivery Product Picture
Figure 2. Global Ocular Drug Delivery Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Ocular Drug Delivery Sales Market Share by Application in 2020 & 2026
Figure 6. Hospitals
Figure 7. Ambulatory Surgical Centers
Figure 8. Ophthalmic Clinics
Figure 9. Homecare Settings
Figure 10. Ocular Drug Delivery Report Years Considered
Figure 11. Global Ocular Drug Delivery Market Size 2015-2026 (US$ Million)
Figure 12. Global Ocular Drug Delivery Sales 2015-2026 (K Doses)
Figure 13. Global Ocular Drug Delivery Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Ocular Drug Delivery Sales Market Share by Region (2015-2020)
Figure 15. Global Ocular Drug Delivery Sales Market Share by Region in 2019
Figure 16. Global Ocular Drug Delivery Revenue Market Share by Region (2015-2020)
Figure 17. Global Ocular Drug Delivery Revenue Market Share by Region in 2019
Figure 18. Global Ocular Drug Delivery Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Ocular Drug Delivery Revenue in 2019
Figure 20. Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Figure 22. Global Ocular Drug Delivery Sales Market Share by Type in 2019
Figure 23. Global Ocular Drug Delivery Revenue Market Share by Type (2015-2020)
Figure 24. Global Ocular Drug Delivery Revenue Market Share by Type in 2019
Figure 25. Global Ocular Drug Delivery Market Share by Price Range (2015-2020)
Figure 26. Global Ocular Drug Delivery Sales Market Share by Application (2015-2020)
Figure 27. Global Ocular Drug Delivery Sales Market Share by Application in 2019
Figure 28. Global Ocular Drug Delivery Revenue Market Share by Application (2015-2020)
Figure 29. Global Ocular Drug Delivery Revenue Market Share by Application in 2019
Figure 30. North America Ocular Drug Delivery Sales Growth Rate 2015-2020 (K Doses)
Figure 31. North America Ocular Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Ocular Drug Delivery Sales Market Share by Country in 2019
Figure 33. North America Ocular Drug Delivery Revenue Market Share by Country in 2019
Figure 34. U.S. Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 35. U.S. Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 37. Canada Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Ocular Drug Delivery Market Share by Type in 2019
Figure 39. North America Ocular Drug Delivery Market Share by Application in 2019
Figure 40. Europe Ocular Drug Delivery Sales Growth Rate 2015-2020 (K Doses)
Figure 41. Europe Ocular Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Ocular Drug Delivery Sales Market Share by Country in 2019
Figure 43. Europe Ocular Drug Delivery Revenue Market Share by Country in 2019
Figure 44. Germany Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 45. Germany Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 47. France Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 49. U.K. Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Italy Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 53. Russia Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Ocular Drug Delivery Market Share by Type in 2019
Figure 55. Europe Ocular Drug Delivery Market Share by Application in 2019
Figure 56. Asia Pacific Ocular Drug Delivery Sales Growth Rate 2015-2020 (K Doses)
Figure 57. Asia Pacific Ocular Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Ocular Drug Delivery Sales Market Share by Region in 2019
Figure 59. Asia Pacific Ocular Drug Delivery Revenue Market Share by Region in 2019
Figure 60. China Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 61. China Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 63. Japan Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 65. South Korea Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 67. India Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Australia Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Taiwan Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Indonesia Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Thailand Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Malaysia Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Philippines Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 81. Vietnam Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Ocular Drug Delivery Market Share by Type in 2019
Figure 83. Asia Pacific Ocular Drug Delivery Market Share by Application in 2019
Figure 84. Latin America Ocular Drug Delivery Sales Growth Rate 2015-2020 (K Doses)
Figure 85. Latin America Ocular Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Ocular Drug Delivery Sales Market Share by Country in 2019
Figure 87. Latin America Ocular Drug Delivery Revenue Market Share by Country in 2019
Figure 88. Mexico Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Mexico Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Brazil Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 93. Argentina Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Ocular Drug Delivery Market Share by Type in 2019
Figure 95. Latin America Ocular Drug Delivery Market Share by Application in 2019
Figure 96. Middle East and Africa Ocular Drug Delivery Sales Growth Rate 2015-2020 (K Doses)
Figure 97. Middle East and Africa Ocular Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Ocular Drug Delivery Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Ocular Drug Delivery Revenue Market Share by Country in 2019
Figure 100. Turkey Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Turkey Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 103. Saudi Arabia Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 105. U.A.E Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Ocular Drug Delivery Market Share by Type in 2019
Figure 107. Middle East and Africa Ocular Drug Delivery Market Share by Application in 2019
Figure 108. OCULAR THERAPEUTIX, INC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Alimera Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Allergan, Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. EyeGate Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Valeant Pharmaceuticals International, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Envisia Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Clearside Biomedical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Graybug Vision Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Taiwan Liposome Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Santen Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. North America Ocular Drug Delivery Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 119. North America Ocular Drug Delivery Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Europe Ocular Drug Delivery Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 121. Europe Ocular Drug Delivery Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Asia Pacific Ocular Drug Delivery Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 123. Asia Pacific Ocular Drug Delivery Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Latin America Ocular Drug Delivery Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 125. Latin America Ocular Drug Delivery Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Middle East and Africa Ocular Drug Delivery Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 127. Middle East and Africa Ocular Drug Delivery Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Porter's Five Forces Analysis
Figure 129. Channels of Distribution
Figure 130. Distributors Profiles
Figure 131. Bottom-up and Top-down Approaches for This Report
Figure 132. Data Triangulation
Figure 133. Key Executives Interviewed
Figure 1. Ocular Drug Delivery Product Picture
Figure 2. Global Ocular Drug Delivery Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Ocular Drug Delivery Sales Market Share by Application in 2020 & 2026
Figure 6. Hospitals
Figure 7. Ambulatory Surgical Centers
Figure 8. Ophthalmic Clinics
Figure 9. Homecare Settings
Figure 10. Ocular Drug Delivery Report Years Considered
Figure 11. Global Ocular Drug Delivery Market Size 2015-2026 (US$ Million)
Figure 12. Global Ocular Drug Delivery Sales 2015-2026 (K Doses)
Figure 13. Global Ocular Drug Delivery Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Ocular Drug Delivery Sales Market Share by Region (2015-2020)
Figure 15. Global Ocular Drug Delivery Sales Market Share by Region in 2019
Figure 16. Global Ocular Drug Delivery Revenue Market Share by Region (2015-2020)
Figure 17. Global Ocular Drug Delivery Revenue Market Share by Region in 2019
Figure 18. Global Ocular Drug Delivery Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Ocular Drug Delivery Revenue in 2019
Figure 20. Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Figure 22. Global Ocular Drug Delivery Sales Market Share by Type in 2019
Figure 23. Global Ocular Drug Delivery Revenue Market Share by Type (2015-2020)
Figure 24. Global Ocular Drug Delivery Revenue Market Share by Type in 2019
Figure 25. Global Ocular Drug Delivery Market Share by Price Range (2015-2020)
Figure 26. Global Ocular Drug Delivery Sales Market Share by Application (2015-2020)
Figure 27. Global Ocular Drug Delivery Sales Market Share by Application in 2019
Figure 28. Global Ocular Drug Delivery Revenue Market Share by Application (2015-2020)
Figure 29. Global Ocular Drug Delivery Revenue Market Share by Application in 2019
Figure 30. North America Ocular Drug Delivery Sales Growth Rate 2015-2020 (K Doses)
Figure 31. North America Ocular Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Ocular Drug Delivery Sales Market Share by Country in 2019
Figure 33. North America Ocular Drug Delivery Revenue Market Share by Country in 2019
Figure 34. U.S. Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 35. U.S. Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 37. Canada Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Ocular Drug Delivery Market Share by Type in 2019
Figure 39. North America Ocular Drug Delivery Market Share by Application in 2019
Figure 40. Europe Ocular Drug Delivery Sales Growth Rate 2015-2020 (K Doses)
Figure 41. Europe Ocular Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Ocular Drug Delivery Sales Market Share by Country in 2019
Figure 43. Europe Ocular Drug Delivery Revenue Market Share by Country in 2019
Figure 44. Germany Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 45. Germany Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 47. France Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 49. U.K. Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Italy Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 53. Russia Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Ocular Drug Delivery Market Share by Type in 2019
Figure 55. Europe Ocular Drug Delivery Market Share by Application in 2019
Figure 56. Asia Pacific Ocular Drug Delivery Sales Growth Rate 2015-2020 (K Doses)
Figure 57. Asia Pacific Ocular Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Ocular Drug Delivery Sales Market Share by Region in 2019
Figure 59. Asia Pacific Ocular Drug Delivery Revenue Market Share by Region in 2019
Figure 60. China Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 61. China Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 63. Japan Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 65. South Korea Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 67. India Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Australia Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Taiwan Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Indonesia Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Thailand Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Malaysia Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Philippines Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 81. Vietnam Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Ocular Drug Delivery Market Share by Type in 2019
Figure 83. Asia Pacific Ocular Drug Delivery Market Share by Application in 2019
Figure 84. Latin America Ocular Drug Delivery Sales Growth Rate 2015-2020 (K Doses)
Figure 85. Latin America Ocular Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Ocular Drug Delivery Sales Market Share by Country in 2019
Figure 87. Latin America Ocular Drug Delivery Revenue Market Share by Country in 2019
Figure 88. Mexico Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Mexico Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Brazil Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 93. Argentina Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Ocular Drug Delivery Market Share by Type in 2019
Figure 95. Latin America Ocular Drug Delivery Market Share by Application in 2019
Figure 96. Middle East and Africa Ocular Drug Delivery Sales Growth Rate 2015-2020 (K Doses)
Figure 97. Middle East and Africa Ocular Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Ocular Drug Delivery Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Ocular Drug Delivery Revenue Market Share by Country in 2019
Figure 100. Turkey Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Turkey Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 103. Saudi Arabia Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)
Figure 105. U.A.E Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Ocular Drug Delivery Market Share by Type in 2019
Figure 107. Middle East and Africa Ocular Drug Delivery Market Share by Application in 2019
Figure 108. OCULAR THERAPEUTIX, INC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Alimera Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Allergan, Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. EyeGate Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Valeant Pharmaceuticals International, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Envisia Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Clearside Biomedical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Graybug Vision Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Taiwan Liposome Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Santen Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. North America Ocular Drug Delivery Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 119. North America Ocular Drug Delivery Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Europe Ocular Drug Delivery Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 121. Europe Ocular Drug Delivery Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Asia Pacific Ocular Drug Delivery Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 123. Asia Pacific Ocular Drug Delivery Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Latin America Ocular Drug Delivery Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 125. Latin America Ocular Drug Delivery Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Middle East and Africa Ocular Drug Delivery Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 127. Middle East and Africa Ocular Drug Delivery Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Porter's Five Forces Analysis
Figure 129. Channels of Distribution
Figure 130. Distributors Profiles
Figure 131. Bottom-up and Top-down Approaches for This Report
Figure 132. Data Triangulation
Figure 133. Key Executives Interviewed
